Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.58 USD | +0.46% | +6.13% | +45.58% |
02/04 | ADMA Biologics, Inc. Announces Promotion of Kaitlin Kestenberg as Chief Operating Officer | CI |
26/03 | HC Wainwright Adjusts ADMA Biologics Price Target to $7.50 From $6, Maintains Buy Rating | MT |
Evolution of the average Target Price on ADMA Biologics, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering ADMA Biologics, Inc.
HC Wainwright | |
Mizuho Securities | |
Raymond James | |
Cantor Fitzgerald | |
Chardan |
EPS Revisions
- Stock Market
- Equities
- ADMA Stock
- Consensus ADMA Biologics, Inc.